Pain Symptoms in Patients with Coronavirus Disease (COVID-19): A Literature Review

Lin-Man Weng, Xuan Su, Xue-Qiang Wang, Lin-Man Weng, Xuan Su, Xue-Qiang Wang

Abstract

Purpose: On 11 March, 2020, the coronavirus disease (COVID-19) outbreak was declared as a global pandemic by the World Health Organization. It brought substantial physical and psychological burden on individuals and financial loss across countries. Patients with COVID-19 may exhibit various symptoms, such as fever, cough, dyspnea, muscle pain, sore throat, headache, chest pain, and abdominal pain, at 2-14 days after exposure to the novel coronavirus (severe acute respiratory syndrome [SARS]-CoV-2). Pain symptoms present important challenge to clinicians' diagnosis when treating COVID-19 patients with mild symptoms. Considering the increasing number of confirmed COVID-19 cases, the pain symptoms should be systematically summarized.

Results: The virus can invade different tissues of the body and cause different pain manifestations. SARS-CoV-2 primarily invades the respiratory system, and patients develop sore throat, fever, cough, and other pneumonia-associated symptoms. Moreover, it infects the nervous system (eg, headache, dizziness, and confusion), digestive system (eg, abdominal pain, diarrhea), and cardiovascular system (eg, chest pain, palmus, and cardiac injury). The incidence rate is 1.7-33.9% for headache, 0.7-47.1% for sore throat, 1.5-61.0% for myalgia/arthralgia, 1.6-17.7% for chest pain, and 1.9-14.5% for abdominal pain. In comparison with chest and abdominal pain, COVID-19 patients are more likely to develop headache, sore throat, and myalgia/arthralgia.

Conclusion: Different pain reflects the damage of different body systems. Therefore, the summary of pain symptoms for COVID-19 patients can help doctors improve the accuracy and efficiency of diagnosis when treating COVID-19 patients with atypical or mild symptoms and adopt more targeted treatment methods.

Keywords: COVID-19; SARS-CoV-2; pain; symptom.

Conflict of interest statement

The authors report no conflicts of interest in this work.

© 2021 Weng et al.

Figures

Figure 1
Figure 1
The incidence rate of pain symptoms for patients with COVID-19.

References

    1. WHO. WHO Director-General’s opening remarks at the media briefing on COVID-19–11 March 2020; 2020. Available from: .
    1. WHO. Coronavirus disease (COVID-2019) situation reports; 2020. Available from: . Accessed January13, 2021.
    1. Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020;395(10231):1225–1228. doi:10.1016/S0140-6736(20)30627-9
    1. Zhang H, Tang K, Fang R, Sun Q. What dermatologists could do to cope with the novel coronavirus (SARS-CoV-2): a dermatologist’s perspective from China. J Eur Acad Dermatol Venereol. 2020;34. doi:10.1111/jdv.16389
    1. Bayham J, Fenichel EP. Impact of school closures for COVID-19 on the US health-care workforce and net mortality: a modelling study. Lancet Public Health. 2020;5:e271–e278. doi:10.1016/S2468-2667(20)30082-7
    1. Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395(10227):912–920. doi:10.1016/S0140-6736(20)30460-8
    1. Cavallo JJ, Forman HP. The economic impact of the COVID-19 pandemic on radiology practices. Radiology. 2020;296:201495. doi:10.1148/radiol.2020201495
    1. Chow EJ, Schwartz NG, Tobolowsky FA, et al. Symptom screening at illness onset of health care personnel with SARS-CoV-2 infection in King County, Washington. JAMA. 2020;323:2087. doi:10.1001/jama.2020.6637
    1. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720.
    1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
    1. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7
    1. Li K, Wu J, Wu F, et al. The clinical and chest CT features associated with severe and critical COVID-19 pneumonia. Invest Radiol. 2020;55:327–331. doi:10.1097/RLI.0000000000000672
    1. Cheung KS, Hung IF, Chan PP, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort and systematic review and meta-analysis. Gastroenterology. 2020.
    1. Pan L, Mu M, Yang P, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020;115:766–773. doi:10.14309/ajg.0000000000000620
    1. Zhu J, Ji P, Pang J, et al. Clinical characteristics of 3062 COVID-19 patients: a meta-analysis. J Med Virol. 2020.
    1. Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368:m606. doi:10.1136/bmj.m606
    1. Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809–815. doi:10.1016/S0140-6736(20)30360-3
    1. Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289(21):2801–2809. doi:10.1001/jama.289.21.JOC30885
    1. Choi KW, Chau TN, Tsang O, et al. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med. 2003;139(9):715–723. doi:10.7326/0003-4819-139-9-200311040-00005
    1. Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348(20):1986–1994. doi:10.1056/NEJMoa030685
    1. Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348(20):1977–1985. doi:10.1056/NEJMoa030666
    1. Onwuchekwa CR, Onwuchekwa AC. The role of computed tomography in the diagnostic work-up of headache patients in Nigeria. Headache. 2010;50(8):1346–1352. doi:10.1111/j.1526-4610.2010.01712.x
    1. Stovner L, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27(3):193–210. doi:10.1111/j.1468-2982.2007.01288.x
    1. Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol. 2008;7(4):354–361. doi:10.1016/S1474-4422(08)70062-0
    1. Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. Eur Respir J. 2020;55:2000547. doi:10.1183/13993003.00547-2020
    1. COVID-19 National Incident Room Surveillance Team. COVID-19, Australia: epidemiology report 11 (Reporting week to 23:59 AEST 12 April 2020). Commun Dis Intell (2018). 2020;44.
    1. Cai Q, Huang D, Ou P, et al. COVID-19 in a designated infectious diseases hospital outside Hubei Province, China. Allergy. 2020;75:1742–1752. doi:10.1111/all.14309
    1. Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762–768. doi:10.1093/cid/ciaa248
    1. Neurath MF. Covid-19 and immunomodulation in IBD. Gut. 2020;69:1335–1342. doi:10.1136/gutjnl-2020-321269
    1. Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis. 2005;5(11):718–725. doi:10.1016/S1473-3099(05)70270-X
    1. Marchioni E, Minoli L. Headache attributed to infections nosography and differential diagnosis. Handb Clin Neurol. 2010;97:601–626.
    1. Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020.
    1. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–1069. doi:10.1001/jama.2020.1585
    1. Mo P, Xing Y, Xiao Y, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis. 2020. doi:10.1093/cid/ciaa270
    1. Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;82(15):7264–7275. doi:10.1128/JVI.00737-08
    1. Li K, Wohlford-Lenane C, Perlman S, et al. Middle east respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J Infect Dis. 2016;213(5):712–722. doi:10.1093/infdis/jiv499
    1. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020.
    1. Li Z, Liu T, Yang N, et al. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain. Front Med. 2020;14(5):533–541. doi:10.1007/s11684-020-0786-5
    1. Panariello F, Cellini L, Speciani M, De Ronchi D, Atti AR. How does SARS-CoV-2 affect the central nervous system? A working hypothesis. Front Psychiatry. 2020;11:582345. doi:10.3389/fpsyt.2020.582345
    1. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683.
    1. Gautier JF, Ravussin Y. A new symptom of COVID-19: loss of taste and smell. Obesity (Silver Spring). 2020;28:848. doi:10.1002/oby.22809
    1. Das G, Mukherjee N, Ghosh S. Neurological insights of COVID-19 pandemic. ACS Chem Neurosci. 2020;11:1206–1209. doi:10.1021/acschemneuro.0c00201
    1. Hu X, Xing Y, Jia J, et al. Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19. Sci Total Environ. 2020;728:138812. doi:10.1016/j.scitotenv.2020.138812
    1. Turner R, Wevrett SR, Edmunds S, et al. Determination of the permeation and penetration of flurbiprofen into cadaveric human pharynx tissue. Clin Pharmacol. 2020;12:13–20. doi:10.2147/CPAA.S234227
    1. Essack S, Bell J, Burgoyne DS, Duerden M, Shephard A. Topical (local) antibiotics for respiratory infections with sore throat: an antibiotic stewardship perspective. J Clin Pharm Ther. 2019;44(6):829–837. doi:10.1111/jcpt.13012
    1. Hayward G, Thompson MJ, Perera R, Glasziou PP, Del Mar CB, Heneghan CJ. Corticosteroids as standalone or add-on treatment for sore throat. Cochrane Database Syst Rev. 2012;10:Cd008268. doi:10.1002/14651858.CD008268.pub2
    1. de Looze F, Shephard A, Smith AB. Locally delivered flurbiprofen 8.75 mg for treatment and prevention of sore throat: a narrative review of clinical studies. J Pain Res. 2019;12:3477–3509. doi:10.2147/JPR.S221706
    1. Weckmann G, Hauptmann-Voss A, Baumeister SE, Klotzer C, Chenot JF. Efficacy of AMC/DCBA lozenges for sore throat: a systematic review and meta-analysis. Int J Clin Pract. 2017;71(10):e13002. doi:10.1111/ijcp.13002
    1. Ng GJ, Tan S, Vu AN, Del Mar CB, van Driel ML, Antibiotics for preventing recurrent sore throat. Cochrane Database Syst Rev. 2015;7:Cd008911. doi:10.1002/14651858.CD008911.pub2
    1. Oxford JS, Leuwer M. Acute sore throat revisited: clinical and experimental evidence for the efficacy of over-the-counter AMC/DCBA throat lozenges. Int J Clin Pract. 2011;65(5):524–530. doi:10.1111/j.1742-1241.2011.02644.x
    1. Garg S, Kim L, Whitaker M, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed Coronavirus disease 2019 - COVID-NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):458–464. doi:10.15585/mmwr.mm6915e3
    1. Pung R, Chiew CJ, Young BE, et al. Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures. Lancet. 2020;395(10229):1039–1046. doi:10.1016/S0140-6736(20)30528-6
    1. Xia S, Liu M, Wang C, et al. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res. 2020;30(4):343–355. doi:10.1038/s41422-020-0305-x
    1. Grant WB, Lahore H, McDonnell SL, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12(4).
    1. Krajewska J, Krajewski W, Zub K, Zatonski T. COVID-19 in otolaryngologist practice: a review of current knowledge. Eur Arch Otorhinolaryngol. 2020;277:1885–1897. doi:10.1007/s00405-020-05968-y
    1. Yan CH, Faraji F, Prajapati DP, Boone CE, DeConde AS. Association of chemosensory dysfunction and Covid-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol. 2020;10:806–813. doi:10.1002/alr.22579
    1. Gorse GJ, Donovan MM, Patel GB, Balasubramanian S, Lusk RH. Coronavirus and other respiratory illnesses comparing older with young adults. Am J Med. 2015;128(11):1251.e1211–1220. doi:10.1016/j.amjmed.2015.05.034
    1. Lechien JR, Chiesa-Estomba CM, Place S, et al. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate Coronavirus disease 2019. J Intern Med. 2020;288:335–344. doi:10.1111/joim.13089
    1. Chan EK, Kornberg AJ, Ryan MM. A diagnostic approach to recurrent myalgia and rhabdomyolysis in children. Arch Dis Child. 2015;100(8):793–797. doi:10.1136/archdischild-2014-307663
    1. Kyriakides T, Angelini C, Schaefer J, et al. EFNS review on the role of muscle biopsy in the investigation of myalgia. Eur J Neurol. 2013;20(7):997–1005. doi:10.1111/ene.12174
    1. Queme LF, Ross JL, Jankowski MP. Peripheral mechanisms of ischemic myalgia. Front Cell Neurosci. 2017;11:419. doi:10.3389/fncel.2017.00419
    1. Irwin ML, Cartmel B, Gross CP, et al. Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors. J Clin Oncol. 2015;33(10):1104–1111. doi:10.1200/JCO.2014.57.1547
    1. Castel LD, Hartmann KE, Mayer IA, et al. Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort. Cancer. 2013;119(13):2375–2382. doi:10.1002/cncr.28016
    1. Tian Z, Wang DS, Wang XS, et al. Analgesic effects of NB001 on mouse models of arthralgia. Mol Brain. 2015;8(1):60. doi:10.1186/s13041-015-0151-9
    1. Luque-Suarez A, Martinez-Calderon J, Falla D. Role of kinesiophobia on pain, disability and quality of life in people suffering from chronic musculoskeletal pain: a systematic review. Br J Sports Med. 2019;53(9):554–559. doi:10.1136/bjsports-2017-098673
    1. Li X, Zeng W, Li X, et al. CT imaging changes of corona virus disease 2019(COVID-19): a multi-center study in Southwest China. J Transl Med. 2020;18(1):154. doi:10.1186/s12967-020-02324-w
    1. Manjavachi MN, Motta EM, Marotta DM, Leite DF, Calixto JB. Mechanisms involved in IL-6-induced muscular mechanical hyperalgesia in mice. Pain. 2010;151(2):345–355. doi:10.1016/j.pain.2010.07.018
    1. Drożdżal S, Rosik J, Lechowicz K, et al. COVID-19: pain management in patients with SARS-CoV-2 infection-molecular mechanisms, challenges, and perspectives. Brain Sci. 2020;10(7):465. doi:10.3390/brainsci10070465
    1. Khodabukus A, Kaza A, Wang J, et al. Tissue-engineered human myobundle system as a platform for evaluation of skeletal muscle injury biomarkers. Toxicol Sci. 2020;176:124–136. doi:10.1093/toxsci/kfaa049
    1. Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020;9(1):45. doi:10.1186/s40249-020-00662-x
    1. Ding Y, He L, Zhang Q, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 2004;203(2):622–630. doi:10.1002/path.1560
    1. Tostmann A, Bradley J, Bousema T, et al. Strong associations and moderate predictive value of early symptoms for SARS-CoV-2 test positivity among healthcare workers, the Netherlands, March 2020. Euro Surveill. 2020;25(16). doi:10.2807/1560-7917.ES.2020.25.16.2000508.
    1. Jin M, Tong Q. Rhabdomyolysis as potential late complication associated with COVID-19. Emerg Infect Dis. 2020;26(7):1618–1620. doi:10.3201/eid2607.200445
    1. Chen LL, Hsu CW, Tian YC, Fang JT. Rhabdomyolysis associated with acute renal failure in patients with severe acute respiratory syndrome. Int J Clin Pract. 2005;59(10):1162–1166. doi:10.1111/j.1368-5031.2005.00540.x
    1. Nance JR, Mammen AL. Diagnostic evaluation of rhabdomyolysis. Muscle Nerve. 2015;51(6):793–810. doi:10.1002/mus.24606
    1. Joob B, Wiwanitkit V. Arthralgia as an initial presentation of COVID-19: observation. Rheumatol Int. 2020;40(5):823. doi:10.1007/s00296-020-04561-0
    1. Ruigomez A, Rodriguez LA, Wallander MA, Johansson S, Jones R. Chest pain in general practice: incidence, comorbidity and mortality. Fam Pract. 2006;23(2):167–174. doi:10.1093/fampra/cmi124
    1. Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802.
    1. COVID-19 National Incident Room Surveillance Team. COVID-19, Australia: epidemiology report 9 (reporting week to 23:59 AEDT 29 March 2020). Commun Dis Intell (2018). 2020;44.
    1. Wang R, Pan M, Zhang X, et al. Epidemiological and clinical features of 125 hospitalized patients with COVID-19 in Fuyang, Anhui, China. Int J Infect Dis. 2020.
    1. Oudit GY, Kassiri Z, Jiang C, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009;39(7):618–625. doi:10.1111/j.1365-2362.2009.02153.x
    1. Reamy BV, Williams PM, Odom MR. Pleuritic chest pain: sorting through the differential diagnosis. Am Fam Physician. 2017;96(5):306–312.
    1. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259–260. doi:10.1038/s41569-020-0360-5
    1. Leung C. Risk factors for predicting mortality in elderly patients with COVID-19: a review of clinical data in China. Mech Ageing Dev. 2020;188:111255. doi:10.1016/j.mad.2020.111255
    1. Wu Q, Zhou L, Sun X, et al. Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci Rep. 2017;7(1):9110. doi:10.1038/s41598-017-09536-z
    1. Viniol A, Keunecke C, Biroga T, et al. Studies of the symptom abdominal pain – a systematic review and meta-analysis. Fam Pract. 2014;31(5):517–529. doi:10.1093/fampra/cmu036
    1. Bharucha AE, Chakraborty S, Sletten CD. Common functional gastroenterological disorders associated with abdominal pain. Mayo Clin Proc. 2016;91(8):1118–1132. doi:10.1016/j.mayocp.2016.06.003
    1. Walter SA, Jones MP, Talley NJ, et al. Abdominal pain is associated with anxiety and depression scores in a sample of the general adult population with no signs of organic gastrointestinal disease. Neurogastroenterol Motil. 2013;25(9):741–e576. doi:10.1111/nmo.12155
    1. Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75:1730–1741. doi:10.1111/all.14238
    1. Zhou S, Wang Y, Zhu T, Xia L. CT features of Coronavirus disease 2019 (COVID-19) pneumonia in 62 patients in Wuhan, China. AJR Am J Roentgenol. 2020;1–8.
    1. Luo S, Zhang X, Xu H. Don’t overlook digestive symptoms in patients with 2019 novel Coronavirus disease (COVID-19). Clin Gastroenterol Hepatol. 2020;18:1636–1637. doi:10.1016/j.cgh.2020.03.043
    1. Harmer D, Gilbert M, Borman R, Clark KL. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. 2002;532(1–2):107–110. doi:10.1016/S0014-5793(02)03640-2
    1. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158(6):1831–1833.e1833. doi:10.1053/j.gastro.2020.02.055
    1. Moustaki M, Zeis PM, Katsikari M, et al. Mesenteric lymphadenopathy as a cause of abdominal pain in children with lobar or segmental pneumonia. Pediatr Pulmonol. 2003;35(4):269–273. doi:10.1002/ppul.10254
    1. Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020;51(9):843–851. doi:10.1111/apt.15731
    1. Saeed U, Sellevoll HB, Young VS, Sandbaek G, Glomsaker T, Mala T. Covid-19 may present with acute abdominal pain. Br J Surg. 2020;107:e186–e187. doi:10.1002/bjs.11674
    1. Sun T, Guan J. Novel coronavirus and the central nervous system. Eur J Neurol. 2020;27. doi:10.1111/ene.14227
    1. Tian S, Hu N, Lou J, et al. Characteristics of COVID-19 infection in Beijing. J Infect. 2020;80(4):401–406. doi:10.1016/j.jinf.2020.02.018
    1. Xu YH, Dong JH, An WM, et al. Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2. J Infect. 2020;80(4):394–400. doi:10.1016/j.jinf.2020.02.017
    1. Yang W, Cao Q, Qin L, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China. J Infect. 2020;80(4):388–393. doi:10.1016/j.jinf.2020.02.016
    1. Guan W-J, Ni Z-Y, Hu Y, et al. Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
    1. Wu J, Liu J, Zhao X, et al. Clinical characteristics of imported cases of Coronavirus disease 2019 (COVID-19) in Jiangsu Province: a multicenter descriptive study. Clin Infect Dis. 2020;71(15):706–712. doi:10.1093/cid/ciaa199
    1. Huang Y, Tu M, Wang S, et al. Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: a retrospective single center analysis. Travel Med Infect Dis. 2020;36:101606. doi:10.1016/j.tmaid.2020.101606
    1. Liu K, Fang YY, Deng Y, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). 2020;133(9):1025–1031. doi:10.1097/CM9.0000000000000744
    1. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
    1. Xu T, Chen C, Zhu Z, et al. Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19. Int J Infect Dis. 2020;94:68–71. doi:10.1016/j.ijid.2020.03.022
    1. Wan S, Xiang Y, Fang W, et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing. J Med Virol. 2020;92(7):797–806. doi:10.1002/jmv.25783
    1. Chen J, Qi T, Liu L, et al. Clinical progression of patients with COVID-19 in Shanghai, China. J Infect. 2020;80(5):e1–e6. doi:10.1016/j.jinf.2020.03.004
    1. COVID-19 National Incident Room Surveillance Team. COVID-19, Australia: epidemiology report 7 (reporting week ending 19:00 AEDT 14 March 2020). Commun Dis Intell (2018). 2020;44.
    1. Zhou S, Wang Y, Zhu T, Xia L. CT features of Coronavirus disease 2019 (COVID-19) pneumonia in 62 patients in Wuhan, China. AJR Am J Roentgenol. 2020;214(6):1287–1294. doi:10.2214/AJR.20.22975
    1. Han R, Huang L, Jiang H, Dong J, Peng H, Zhang D. Early clinical and CT manifestations of Coronavirus disease 2019 (COVID-19) pneumonia. AJR Am J Roentgenol. 2020;215(2):338–343. doi:10.2214/AJR.20.22961
    1. Song F, Shi N, Shan F, et al. Emerging 2019 novel Coronavirus (2019-nCoV) pneumonia. Radiology. 2020;295(1):210–217. doi:10.1148/radiol.2020200274
    1. Qian GQ, Yang NB, Ding F, et al. Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series. QJM. 2020;113(7):474–481. doi:10.1093/qjmed/hcaa089
    1. Spiteri G, Fielding J, Diercke M, et al. First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020. Euro Surveill. 2020;25(9). doi:10.2807/1560-7917.ES.2020.25.9.2000178.
    1. Xu X, Yu C, Qu J, et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging. 2020;47(5):1275–1280. doi:10.1007/s00259-020-04735-9
    1. Zhu W, Xie K, Lu H, Xu L, Zhou S, Fang S. Initial clinical features of suspected coronavirus disease 2019 in two emergency departments outside of Hubei, China. J Med Virol. 2020;92(9):1525–1532. doi:10.1002/jmv.25763
    1. Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425–434. doi:10.1016/S1473-3099(20)30086-4
    1. Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Relation between chest CT findings and clinical conditions of Coronavirus disease (COVID-19) pneumonia: a multicenter study. AJR Am J Roentgenol. 2020;214(5):1072–1077. doi:10.2214/AJR.20.22976
    1. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934–943. doi:10.1001/jamainternmed.2020.0994
    1. Wang Y, Dong C, Hu Y, et al. Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study. Radiology. 2020;296(2):E55–e64. doi:10.1148/radiol.2020200843
    1. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–690.
    1. Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802–810.
    1. on COVID NC. Daily situation report on Coronavirus disease (COVID-19) in Iran; March 13, 2020. Arch Acad Emerg Med. 2020;8(1):e23.
    1. Wang K, Kang S, Tian R, Zhang X, Zhang X, Wang Y. Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area. Clin Radiol. 2020;75(5):341–347. doi:10.1016/j.crad.2020.03.004
    1. Cao J, Tu WJ, Cheng W, et al. Clinical features and short-term outcomes of 102 patients with Coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020;71(15):748–755. doi:10.1093/cid/ciaa243
    1. Zhang R, Ouyang H, Fu L, et al. CT features of SARS-CoV-2 pneumonia according to clinical presentation: a retrospective analysis of 120 consecutive patients from Wuhan city. Eur Radiol. 2020;30(8):4417–4426. doi:10.1007/s00330-020-06854-1
    1. Barrasa H, Rello J, Tejada S, et al. SARS-CoV-2 in Spanish INTENSIVE CARE UNITS: early experience with 15-day survival in Vitoria. Critical Care Pain Med. 2020;39(5):553–561. doi:10.1016/j.accpm.2020.04.001
    1. Tang X, Du RH, Wang R, et al. Comparison of hospitalized patients with ARDS caused by COVID-19 and H1N1. Chest. 2020;158(1):195–205. doi:10.1016/j.chest.2020.03.032
    1. Sun Y, Koh V, Marimuthu K, et al. Epidemiological and clinical predictors of COVID-19. Clin Infect Dis. 2020;71(15):786–792. doi:10.1093/cid/ciaa322
    1. Chen Z, Fan H, Cai J, et al. High-resolution computed tomography manifestations of COVID-19 infections in patients of different ages. Eur J Radiol. 2020;126:108972. doi:10.1016/j.ejrad.2020.108972
    1. Chen Y, Chen L, Deng Q, et al. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients. J Med Virol. 2020;92(7):833–840. doi:10.1002/jmv.25825
    1. Wang X, Fang J, Zhu Y, et al. Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital. Clin Microbiol Infect. 2020;26(8):1063–1068. doi:10.1016/j.cmi.2020.03.032
    1. Shao F, Xu S, Ma X, et al. In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China. Resuscitation. 2020;151:18–23. doi:10.1016/j.resuscitation.2020.04.005
    1. Wang R, Pan M, Zhang X, et al. Epidemiological and clinical features of 125 hospitalized patients with COVID-19 in Fuyang, Anhui, China. Int J Infect Dis. 2020;95:421–428. doi:10.1016/j.ijid.2020.03.070
    1. Du RH, Liu LM, Yin W, et al. Hospitalization and critical care of 109 decedents with COVID-19 pneumonia in Wuhan, China. Ann Am Thorac Soc. 2020;17(7):839–846. doi:10.1513/AnnalsATS.202003-225OC
    1. Jia J, Hu X, Yang F, et al. Epidemiological characteristics on the clustering nature of COVID-19 in Qingdao City, 2020: a descriptive analysis. Disaster Med Public Health Prep. 2020;14(5):643–647. doi:10.1017/dmp.2020.59
    1. Feng Y, Ling Y, Bai T, et al. COVID-19 with different severities: a multicenter study of clinical features. Am J Respir Crit Care Med. 2020;201(11):1380–1388. doi:10.1164/rccm.202002-0445OC
    1. Zheng F, Tang W, Li H, Huang YX, Xie YL, Zhou ZG. Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha. Eur Rev Med Pharmacol Sci. 2020;24(6):3404–3410. doi:10.26355/eurrev_202003_20711
    1. Du Y, Tu L, Zhu P, et al. Clinical features of 85 fatal cases of COVID-19 from Wuhan. A retrospective observational study. Am J Respir Crit Care Med. 2020;201(11):1372–1379. doi:10.1164/rccm.202003-0543OC

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe